Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

7th Annual Evercore HealthCONx Conference

Dec 4, 2024 10:50 AM EST